Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
Clinical trial NCT06821126 · RECRUITING
Trial details
- NCT number
- NCT06821126
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-09
- Primary completion
- 2026-10-01
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.